Freedom Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $297K | Sell |
|
|||||
|
2025
Q1 | $402K | Buy |
|
|||||
|
2024
Q4 | $330K | Buy |
|
|||||
|
2024
Q3 | $340K | Sell |
|
|||||
|
2024
Q2 | $427K | Buy |
|
|||||
|
2024
Q1 | $397K | Sell |
|
|||||
|
2023
Q4 | $476K | Sell |
|
|||||
|
2023
Q3 | $456K | Sell |
|
|||||
|
2023
Q2 | $458K | Sell |
|
|||||
|
2023
Q1 | $555K | Sell |
|
|||||
|
2022
Q4 | $627K | Sell |
|
|||||
|
2022
Q3 | $531K | Sell |
|
|||||
|
2022
Q2 | $542K | Sell |
|
|||||
|
2022
Q1 | $515K | Sell |
|
|||||
|
2021
Q4 | $636K | Sell |
|
|||||
|
2021
Q3 | $568K | Sell |
|
|||||
|
2021
Q2 | $640K | Sell |
|
|||||
|
2021
Q1 | $616K | Sell |
|
|||||
|
2020
Q4 | $1.08M | Sell |
|
|||||
|
2020
Q3 | $1.07M | Sell |
|
|||||
|
2020
Q2 | $1.85M | Sell |
|
|||||
|
2020
Q1 | $1.58M | Buy |
|
|||||
|
2019
Q4 | $1.5M | Sell |
|
|||||
|
2019
Q3 | $1.35M | Sell |
|
|||||
|
2019
Q2 | $2M | Sell |
|
|||||
|
2019
Q1 | $2.2M | Sell |
|
|||||
|
2018
Q4 | $2.14M | Sell |
|
|||||
|
2018
Q3 | $2.59M | Sell |
|
|||||
|
2018
Q2 | $2.65M | Buy |
|
|||||
|
2018
Q1 | $1.5M | Buy |
|
|||||
|
2017
Q4 | $1.62M | Buy |
|
|||||
|
2017
Q3 | $1.65M | Sell |
|
|||||
|
2017
Q2 | $1.68M | Buy |
|
|||||
|
2017
Q1 | $1.62M | Sell |
|
|||||
|
2016
Q4 | $1.73M | Sell |
|
|||||
|
2016
Q3 | $2.42M | Sell |
|
|||||
|
2016
Q2 | $2.09M | Buy |
|
|||||
|
2016
Q1 | $2.12M | Buy |
|
|||||
|
2015
Q4 | $2.65M | Sell |
|
|||||
|
2015
Q3 | $185K | Buy |
|
|||||
|
2015
Q2 | $2.28M | Buy |
|
|||||
|
2015
Q1 | $1.47M | Buy |
|
|||||
|
2014
Q4 | $541K | Buy |
|